Skip to main content

Table 3 Multiple logistic regression analysis showing the parameters with significant independent associations with subclinical atherosclerosis

From: Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes

 

Men (n = 107)

Women (n = 105)

 

Model 1

Model 2

Model 1

Model 2

Parameters

OR(95 % CI)

P value

OR(95 % CI)

P value

OR(95 % CI)

P value

OR(95 % CI)

P value

Age

1.01(0.95–1.07)

0.828

0.99(0.93–1.05)

0.718

1.17(1.02–1.33)

0.021

1.15(1.01–1.30)

0.040

Smoking

1.07(0.30–3.73)

0.921

1.25(0.38–4.15)

0.715

3.68(0.13–104.52)

0.455

4.23(0.18–97.23)

0.368

Family history of cardiovascular diseases

6.411(1.82–22.56)

0.004

4.18(1.31–13.35)

0.016

4.02(1.11–14.55)

0.034

4.16(1.16–14.98)

0.029

Menopause status

-

-

-

-

1.24(0.08–19.68)

0.877

1.39(0.08–23.30)

0.818

Body mass index

1.27(1.02–1.59)

0.036

-

-

1.18(0.90–1.55)

0.235

-

-

Waist circumference

-

-

0.98(0.90–1.05)

0.540

-

-

1.02(0.95–1.09)

0.661

Hypertension

0.82(0.19–3.50)

0.790

1.11(0.28–4.43)

0.887

0.59(0.15–2.36)

0.459

0.63(0.16–2.49)

0.510

Dyslipidemia

0.35(0.10–1.22)

0.100

0.38(0.11–1.28)

0.117

3.36(0.71–15.77)

0.125

3.18(0.70–14.53)

0.135

Fasting glucose

0.91(0.72–1.15)

0.435

0.96(0.78–1.19)

0.714

1.04(0.91–1.19)

0.583

1.03(0.90–1.17)

0.677

Fasting insulina

0.46(0.15–1.43)

0.181

0.79(0.28–2.25)

0.656

0.63(0.20–1.96)

0.420

0.87(0.32–2.34)

0.781

Fibroblast growth factor 21a

2.20(1.17–4.13)

0.014

1.98(1.09–3.60)

0.026

3.08(1.12–8.42)

0.029

2.90(1.07–7.86)

0.037

  1. aLog-transformed before analyses